Claims for Patent: 11,141,540

Summary for Patent: 11,141,540

Title:	Syringe devices
Abstract:	Described herein are syringe devices comprising a syringe including a therapeutic dose of at least one drug and a stopper. The syringe is housed and/or placed in an encasement. The plunger assembly can include a plunger, an actuator, and a spacer, wherein the plunger assembly is configured to move the stopper a predetermined distance without a user touching the plunger. Methods of assembling and using the syringe devices are also described.
Inventor(s):	Rolfs; Bryan E. (St. Paul, MN), Flather; Mark J. (San Diego, CA), Daniels; Karen K. (San Diego, CA), Moll; Thomas (San Diego, CA)
Assignee:	Adamis Pharmaceuticals Corporation (San Diego, CA)
Application Number:	15/754,569
Patent Claims:	1. A syringe device comprising: a syringe including a therapeutic dose of at least one drug and a stopper; and a plunger assembly including a plunger rod, an actuator including an actuator ring, and a spacer including a top stop and a bottom stop, wherein the plunger rod is configured to attach to the actuator and direct the actuator ring from the top stop to the bottom stop, wherein the spacer is attached around part of the plunger rod and is opposite the actuator, and wherein the plunger assembly is configured to move the stopper a predetermined distance without a user touching the plunger rod or being able to retract the plunger rod. 2. The syringe device of claim 1, wherein the plunger assembly is configured to provide substantially identical doses of the at least one drug even if more or less of the at least one drug is provided in the syringe by moving the stopper a predetermined distance. 3. The syringe device of claim 1, further including: an encasement configured to house the syringe. 4. The syringe device of claim 3, wherein the encasement includes a window configured to allow the user to view the at least one drug in the syringe. 5. The syringe device of claim 1, wherein the therapeutic dose of the at least one drug is about 0.1 cc to 1 cc. 6. The syringe device of claim 1, wherein the therapeutic dose of the at least one drug is about 0.5 cc. 7. The syringe device of claim 1, wherein the at least one drug is an adrenergic receptor agonist or antagonist, anti-proliferative, estrogen, chaperone inhibitor, protease inhibitor, protein-tyrosine kinase inhibitor, peroxisome proliferator-activated receptor gamma ligand (PPAR.gamma.), epidermal growth factor inhibitor, proteasome inhibitor, anti-inflammatory, anti-sense nucleotide, transforming nucleic acid, anti-proliferative compound, cytostatic compound, toxic compound, chemotherapeutic agent, analgesic, protease inhibitor, statin, nucleic acid, polypeptide, growth factor, delivery vector, anti-diabetic agent, secretagogue, vitamin, vaccine, steroid, narcotic, hormone, biological response modifier, antibiotic, antiviral agent, anesthetic, anorexic, antiarthritic, antiasthmatic, anticonvulsant, antidepressant, antigen, antihistamine, antinauseant, antineoplastic, antipruritic, antipsychotic, antipyretic, antispasmodic, calcium channel blocker, beta-blocker, beta-agonist, antiarrythmic, antihypertensive, diuretic, vasodilator, stimulant, decongestant, immunosuppressive, muscle relaxant, psychostimulant, sedative, tranquilizer, or a combination thereof. 8. The syringe device of claim 1, wherein the at least one drug is epinephrine or a salt thereof. 9. The syringe device of claim 8, wherein the syringe device is configured to deliver about 0.15 mg or about 0.3 mg of epinephrine or a salt thereof. 10. The syringe device of claim 1, wherein the at least one drug is glucagon. 11. The syringe device of claim 1, wherein the actuator and the spacer are configured to be secured around the plunger rod. 12. The syringe device of claim 1, wherein the actuator includes a finger depression location. 13. The syringe device of claim 1 configured for use in an emergency. 14. A method for administering a therapeutic dose of at least one drug, the method comprising: advancing a stopper through a syringe including the therapeutic dose of the at least one drug; wherein the stopper is only advanced a predetermined distance by a plunger assembly including a plunger rod, an actuator including an actuator ring, and a spacer including a top stop and a bottom stop, wherein the plunger rod is configured to attach to the actuator and direct the actuator ring from the top stop to the bottom stop, wherein the spacer is attached around part of the plunger rod and is opposite the actuator, and wherein the plunger assembly is configured to move the stopper without a user touching the plunger rod. 15. The method of claim 14, wherein the syringe is housed in an encasement. 16. The method of claim 15, wherein the encasement includes a window configured to allow the user to view the at least one drug in the syringe. 17. The method of claim 14, wherein the therapeutic dose of at least one drug is about 0.1 cc to 1 cc. 18. The method of claim 14, wherein the therapeutic dose of at least one drug is about 0.5 cc. 19. The method of claim 14, wherein advancing the stopper the predetermined distance is configured to deliver about 0.15 mg or about 0.3 mg of the at least one drug. 20. The method of claim 14, wherein the at least one drug is an adrenergic receptor agonist or antagonist, anti-proliferative, estrogen, chaperone inhibitor, protease inhibitor, protein-tyrosine kinase inhibitor, peroxisome proliferator-activated receptor gamma ligand (PPARy), epidermal growth factor inhibitor, proteasome inhibitor, anti-inflammatory, anti-sense nucleotide, transforming nucleic acid, anti-proliferative compound, cytostatic compound, toxic compound, chemotherapeutic agent, analgesic, protease inhibitor, statin, nucleic acid, polypeptide, growth factor, delivery vector, anti-diabetic agent, secretagogue, vitamin, vaccine, steroid, narcotic, hormone, biological response modifier, antibiotic, antiviral agent, anesthetic, anorexic, antiarthritic, antiasthmatic, anticonvulsant, antidepressant, antigen, antihistamine, antinauseant, antineoplastic, antipruritic, antipsychotic, antipyretic, antispasmodic, calcium channel blocker, beta-blocker, beta-agonist, antiarrythmic, antihypertensive, diuretic, vasodilator, stimulant, decongestant, immunosuppressive, muscle relaxant, psychostimulant, sedative, tranquilizer, or a combination thereof. 21. The method of claim 20, wherein the at least one drug is epinephrine or a salt thereof or glucagon or a salt thereof. 22. The method of claim 14, wherein the actuator and the spacer are configured to be secured around the plunger rod and provide the predetermined distance. 23. The method of claim 14, wherein the actuator and the spacer are configured to provide the predetermined distance between a start point and an end point.